Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1032 | 949 | 1032 | 1061 | 1383 | 2454 |
Fund Return | 3.24% | -5.07% | 3.24% | 1.99% | 6.7% | 9.39% |
Place in category | 336 | 604 | 336 | 124 | 103 | 69 |
% in Category | 34 | 62 | 34 | 21 | 21 | 23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.73B | 27.25 | 11.20 | 15.12 | ||
Legal General US Index Trust C Dist | 892.81M | 27.22 | 11.20 | 15.12 | ||
Legal General US Index Trust F Acc | 581.42K | 26.93 | 10.90 | 14.79 | ||
Legal General US Index Trust F Dist | 24.57K | 26.85 | 10.88 | 14.78 | ||
Legal General US Index Trust I Acc | 1.75B | 27.16 | 11.15 | 15.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 4B | 5.16 | 5.09 | 10.55 | ||
Wellington Global Health Care EquiG | 2.07B | 6.70 | 4.03 | 11.14 | ||
Adamant Medtech I GBP | 1.67B | 10.76 | 0.98 | 12.16 | ||
Global Health Care Fund W Acc GBP | 111.58M | 1.25 | -0.40 | 8.83 | ||
Pharmaceuticals Index Trust F Acc | 268.97K | 3.03 | 1.86 | 9.24 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.67 | 813.51 | +1.17% | |
UnitedHealth | US91324P1021 | 6.67 | 540.23 | +0.40% | |
J&J | US4781601046 | 4.97 | 152.72 | +1.04% | |
AbbVie | US00287Y1091 | 4.65 | 174.75 | -0.29% | |
Novo Nordisk B | DK0062498333 | 4.42 | 603.7 | -0.66% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review